Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

PAOLO SPORTOLETTI

Università degli Studi di Napoli Federico II

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cell Biology

30%

Pharmacotherapy

40%

Lymphoma

40%

Tyrosine Kinase

40%

Targeted Therapy

40%

B Cell Biology

30%

Antibody Therapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study

Article Link

Year:

2023

Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia

Article Link

Year:

2023

Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax

Article Link

Year:

2023

Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement

Article Link

Year:

2022

Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement

Article Link

Year:

2022

The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein

Article Link

Year:

2022

Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia

Article Link

Year:

2022

Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study

Article Link

Year:

2021

A Curious Novel Combination of Nucleophosmin (NPM1) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of NPM1 in Acute Myeloid Leukemia (AML)

Article Link

Year:

2021

Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice

Article Link

Year:

2021

Collaborators13

Luca Laurenti

Università Cattolica del Sacro Cuore

ITALY

Simone FERRERO

University of Turin

ITALY

Francesca Romana Mauro

ITALY

Lorenzo Brunetti

Assistant Professor

Università Politecnica delle Marche

ITALY

Marta COSCIA

Assistant Professor of Hematology

University of Turin

ITALY

Stefano Molica

UNITED KINGDOM

Roberto Marasca

Professore Associato

University of Modena and Reggio Emilia

ITALY

Donato Mannina

Head of Hematology Division

Azienda Ospedale Università Padova

ITALY

Candida VITALE

University of Turin

ITALY

Gianluca GAIDANO

Professor of Hematology

ITALY

Ilaria DEL GIUDICE

Sapienza University of Rome

ITALY

Andrea Visentin

Assistant professor

University of Padua

ITALY

Livio Trentin

ITALY

How do I reach out?

Meet Kite AI